BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 9036015)

  • 21. Schizophrenia, neurobiology and the methodology of systemic modeling.
    Tretter F; Scherer J
    Pharmacopsychiatry; 2006 Feb; 39 Suppl 1():S26-35. PubMed ID: 16508893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of schizophrenia with "atypical antipsychotic drugs". Quality of life as a measure of treatment success].
    Krankenpfl J; 2002; 40(7-9):230-1. PubMed ID: 12514869
    [No Abstract]   [Full Text] [Related]  

  • 23. Strategies of clinical research on neurobiological determinants of psychosis.
    Helmchen H; Gaebel W
    Psychiatr Dev; 1987; 5(1):51-62. PubMed ID: 2885833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A few important points about dopamine's role in neural network dynamics.
    Durstewitz D
    Pharmacopsychiatry; 2006 Feb; 39 Suppl 1():S72-5. PubMed ID: 16508901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopamine, the prefrontal cortex and schizophrenia.
    Knable MB; Weinberger DR
    J Psychopharmacol; 1997; 11(2):123-31. PubMed ID: 9208376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [What criteria for an ideal antipsychotic treatment?].
    Bordet R
    Encephale; 2015 Feb; 41(1):39-46. PubMed ID: 25638050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathophysiologic mechanisms in the pathogenesis and clinical course of schizophrenia.
    Lieberman JA
    J Clin Psychiatry; 1999; 60 Suppl 12():9-12. PubMed ID: 10372603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The complexity of the dopaminergic synapses and their modulation by antipsychotics.
    Leuner K; Müller WE
    Pharmacopsychiatry; 2006 Feb; 39 Suppl 1():S15-20. PubMed ID: 16508891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cognitive neuroscience and schizophrenia: translational research in need of a translator.
    Cohen JD; Insel TR
    Biol Psychiatry; 2008 Jul; 64(1):2-3. PubMed ID: 18549873
    [No Abstract]   [Full Text] [Related]  

  • 30. [Neuroendocrinology and schizophrenia research].
    Müller-Spahn F
    Monogr Gesamtgeb Psychiatr Psychiatry Ser; 1991; 64():1-96. PubMed ID: 1682802
    [No Abstract]   [Full Text] [Related]  

  • 31. [Against: is monotherapy the gold standard of psychopharmacology?].
    Bechter K
    Psychiatr Prax; 2006 Jul; 33(5):208-10. PubMed ID: 16874937
    [No Abstract]   [Full Text] [Related]  

  • 32. Clozapine: the Yin and Yang of seizures and psychosis.
    Stevens JR
    Biol Psychiatry; 1995 Apr; 37(7):425-6. PubMed ID: 7786954
    [No Abstract]   [Full Text] [Related]  

  • 33. Phenomenological modelling of some mechanisms in schizophrenia.
    Schwegler H
    Pharmacopsychiatry; 2006 Feb; 39 Suppl 1():S43-9. PubMed ID: 16508895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Weight gain during treatment with antipsychotics: clinical relevance, pathophysiology, and therapeutical strategies].
    Himmerich H; Schuld A; Pollmächer T
    Psychiatr Prax; 2004 Nov; 31 Suppl 2():S233-7. PubMed ID: 15586316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conventional versus novel antipsychotics: changing concepts and clinical implications.
    Remington G; Chong SA
    J Psychiatry Neurosci; 1999 Nov; 24(5):431-41. PubMed ID: 10586534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurocognitive impairment in schizophrenia and how it affects treatment options.
    Bilder RM
    Can J Psychiatry; 1997 Apr; 42(3):255-64. PubMed ID: 9114941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identify the specific role of regional changes for the complex symptoms of schizophrenia.
    Tretter F; Müller WE; Carlsson A
    Pharmacopsychiatry; 2006 Feb; 39 Suppl 1():S1-2. PubMed ID: 16508887
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clozapine in the treatment of schizophrenia].
    Raitasuo V
    Duodecim; 2000; 116(11):1199-204; quiz 1205. PubMed ID: 11989005
    [No Abstract]   [Full Text] [Related]  

  • 39. [Transmitter dysfunction in patients with schizophrenia. Significance for cognitive functioning and treatment].
    Glenthøj BY; Mackeprang T; Bille AE; Hemmingsen RP
    Ugeskr Laeger; 1999 Mar; 161(10):1391-8. PubMed ID: 10085745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brain-derived neurotrophic factor in schizophrenia and its relation with dopamine.
    Guillin O; Demily C; Thibaut F
    Int Rev Neurobiol; 2007; 78():377-95. PubMed ID: 17349867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.